Abiopharma

(30% Negative) Q32 BIO INC. (QTTB) Reports Q1 2026 Financial Results

(30% Negative) APYX MEDICAL CORPORATION (APYX) Reports Q1 2026 Financial Results

(10% Negative) ZURA BIO LIMITED (ZURA) Announces Delay in identified Development Timeline Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016

General Announcement: CHANGES IN DIRECTORS INTEREST PURSUANT TO SECTION 219 OF THE COMPANIES ACT, 2016

General Announcement: DEALINGS DURING CLOSED PERIOD

New Form 10-K - EXAGEN INC. <b>Filed:</b> 2026-03-10 <b>AccNo:</b> 0001274737-26-000009 <b>Size:</b> 12 MB

(90% Positive) LIPOCINE INC. (LPCN) Reports Q1 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Changes in Interest of Substantial Shareholder - Zhang Haihua

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Changes in Interest of Substantial Shareholders-TGBPL, Tan Tong Guan, Tan Geok Moey & Tan Yoke Hong